V116517
- Generic Name
- V116517
- Drug Type
- Small Molecule
- Chemical Formula
- C19H18ClF3N4O3
- CAS Number
- 1073616-61-1
- Unique Ingredient Identifier
- TBJ73RQT8F
- Background
V116517 is under investigation in clinical trial NCT01688947 (Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)).
Experimental Biomarker Study for Pain Thresholds
Phase 1
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2016-03-01
- Last Posted Date
- 2016-03-01
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 37
- Registration Number
- NCT02695745
- Locations
- 🇩🇰
CCBR A/S, Aalborg, Denmark
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Phase 2
Completed
- Conditions
- Postherpetic NeuralgiaPain
- Interventions
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2014-05-12
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 105
- Registration Number
- NCT01688947
- Locations
- 🇺🇸
Investigational Site, Salt Lake City, Utah, United States
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee
Phase 2
Completed
- Conditions
- Osteoarthritis, KneePain
- Interventions
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 230
- Registration Number
- NCT01688934
- Locations
- 🇺🇸
Jacksonville Center for Clinical Research, Jacksonville, Florida, United States
🇺🇸Avail Clinical Research, LLC, Deland, Florida, United States
🇺🇸Westside Center for Clinical Research, Jacksonville, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath